Document is current
Any future updates will be listed below
-
Authors
Maier, André
Kettemann, Dagmar
Weyen, Ute
Grehl, Torsten
Schulte, Peter Caspar
Steinbach, Robert
Rödiger, Annekathrin
Weydt, Patrick
Petri, Susanne
Wolf, Joachim
Grosskreutz, Julian
Koch, Jan Christoph
Weishaupt, Jochen H.
Rosseau, Simone
Norden, Jenny
Körtvélyessy, Peter
Koch, Birgit
Holm, Teresa
Hildebrandt, Barbara
Schumann, Peggy
Walter, Bertram
Riitano, Alessio
Münch, Christoph
Meyer, Thomas
Spittel, Susanne
-
Funding
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Received: 31 May 2024
Accepted: 21 February 2025
First Online: 1 March 2025
Declarations
:
: AM has received presentation and consulting fees from Merz Pharma GmbH & Co., KGaA, ITF Pharma GmbH, Zambon GmbH and Roche Pharma AG. JCK has received personal fees from AbbVie, Biogen, Ipsen, Roche and Zambon. TM has received consulting fees from Cytokinetics, GSK and Desitin Arzneimittel GmbH, and has served on scientific advisory boards for Cytokinetics, GSK and TEVA. TM and CM are founders of the internet platform Ambulanzpartner and hold shares in Ambulanzpartner Soziotechnologie APST GmbH. SP has participated on advisory boards of Biogen and has received consulting fees from Biogen. AKR received speaker fees from Amylyx Pharmaceuticals and served on advisory boards for Biogen and Argenx outside of the submitted work. All other authors declare that they have no conflicts of interest.
